V. E. Valli

8.3k total citations
224 papers, 4.9k citations indexed

About

V. E. Valli is a scholar working on Immunology, Pulmonary and Respiratory Medicine and Molecular Biology. According to data from OpenAlex, V. E. Valli has authored 224 papers receiving a total of 4.9k indexed citations (citations by other indexed papers that have themselves been cited), including 46 papers in Immunology, 41 papers in Pulmonary and Respiratory Medicine and 38 papers in Molecular Biology. Recurrent topics in V. E. Valli's work include Veterinary Oncology Research (39 papers), Carcinogens and Genotoxicity Assessment (29 papers) and T-cell and Retrovirus Studies (28 papers). V. E. Valli is often cited by papers focused on Veterinary Oncology Research (39 papers), Carcinogens and Genotoxicity Assessment (29 papers) and T-cell and Retrovirus Studies (28 papers). V. E. Valli collaborates with scholars based in Canada, United States and Sweden. V. E. Valli's co-authors include J H Lumsden, D. C. Villeneuve, I. Chu, Robert M. J. Jacobs, Raymond Poon, Pierre Lecavalier, I. Chu, Jonathan L. Heeney, Maung San Myint and Reuben Baumal and has published in prestigious journals such as PLoS ONE, The Science of The Total Environment and Cancer Research.

In The Last Decade

V. E. Valli

218 papers receiving 4.5k citations

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author Last Decade Papers Cites
V. E. Valli 1.6k 1.2k 832 809 702 224 4.9k
William W. Carlton 467 0.3× 357 0.3× 234 0.3× 259 0.3× 329 0.5× 184 3.9k
A. L. Jensen 498 0.3× 1.2k 1.0× 330 0.4× 281 0.3× 215 0.3× 166 5.4k
Timothy A. Reinhardt 283 0.2× 1.1k 0.9× 1.5k 1.8× 287 0.4× 826 1.2× 169 7.9k
Paul Nettesheim 2.3k 1.4× 148 0.1× 443 0.5× 480 0.6× 691 1.0× 241 6.3k
Mark E. Peterson 1.1k 0.7× 4.4k 3.7× 1.3k 1.5× 160 0.2× 210 0.3× 269 8.6k
M I Luster 272 0.2× 838 0.7× 365 0.4× 1.9k 2.4× 2.1k 2.9× 87 5.8k
Mark S. Wilson 1.3k 0.8× 469 0.4× 340 0.4× 176 0.2× 3.8k 5.5× 84 9.4k
Ian Kimber 262 0.2× 575 0.5× 276 0.3× 871 1.1× 2.4k 3.4× 230 8.6k
Christiane V. Löhr 381 0.2× 212 0.2× 309 0.4× 276 0.3× 337 0.5× 143 3.2k
Shri N. Giri 2.6k 1.6× 244 0.2× 144 0.2× 147 0.2× 430 0.6× 198 5.7k

Countries citing papers authored by V. E. Valli

Since Specialization
Citations

This map shows the geographic impact of V. E. Valli's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by V. E. Valli with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites V. E. Valli more than expected).

Fields of papers citing papers by V. E. Valli

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by V. E. Valli. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by V. E. Valli. The network helps show where V. E. Valli may publish in the future.

Co-authorship network of co-authors of V. E. Valli

This figure shows the co-authorship network connecting the top 25 collaborators of V. E. Valli. A scholar is included among the top collaborators of V. E. Valli based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with V. E. Valli. V. E. Valli is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Thamm, Douglas H., Anne C. Avery, Davide Berlato, et al.. (2019). Prognostic and predictive significance of KIT protein expression and c‐kit gene mutation in canine cutaneous mast cell tumours: A consensus of the Oncology‐Pathology Working Group. Veterinary and Comparative Oncology. 17(4). 451–455. 21 indexed citations
2.
Kent, Michael S., Joerg Mayer, João Brandão, et al.. (2012). The use of megavoltage radiation therapy in the treatment of thymomas in rabbits: 19 cases. Veterinary and Comparative Oncology. 10(2). 82–94. 14 indexed citations
3.
Ito, Daisuke, Cristan M. Jubala, Karen M. Helm, et al.. (2011). A Tumor-Related Lymphoid Progenitor Population Supports Hierarchical Tumor Organization in Canine B-Cell Lymphoma. Journal of Veterinary Internal Medicine. 25(4). 890–896. 15 indexed citations
4.
Souza, Carlos Henrique de Mello, V. E. Valli, Kim A. Selting, Matti Kiupel, & Barbara E. Kitchell. (2010). Immunohistochemical Detection of Retinoid Receptors in Tumors from 30 Dogs Diagnosed with Cutaneous Lymphoma. Journal of Veterinary Internal Medicine. 24(5). 1112–1117. 10 indexed citations
5.
Rusk, Anthony, David M. Vail, Joanne C. Graham, et al.. (2006). Cooperative Activity of Cytotoxic Chemotherapy with Antiangiogenic Thrombospondin-I Peptides, ABT-526 in Pet Dogs with Relapsed Lymphoma. Clinical Cancer Research. 12(24). 7456–7464. 20 indexed citations
6.
Lohmiller, Jeffrey J., et al.. (1999). Epidermotropic Lymphoma (Mycosis Fungoides) in an ICR Mouse.. PubMed. 38(5). 47–49. 4 indexed citations
7.
Valli, V. E., Alan Norris, Robert M. J. Jacobs, et al.. (1995). Pathology of canine bladder and urethral cancer and correlation with tumour progression and survival. Journal of Comparative Pathology. 113(2). 113–130. 74 indexed citations
8.
Lecavalier, Pierre, I. Chu, D. C. Villeneuve, & V. E. Valli. (1994). Combined effects of mercury and hexachlorobenzene in the rat. Journal of Environmental Science and Health Part B. 29(5). 951–961. 14 indexed citations
9.
Norris, Alan, Elizabeth J. Laing, V. E. Valli, et al.. (1992). Canine Bladder and Urethral Tumors: A Retrospective Study of 115 Cases (1980–1985). Journal of Veterinary Internal Medicine. 6(3). 145–153. 172 indexed citations
10.
Jacobs, Robert M. J., Jonathan L. Heeney, Michael A. Godkin, et al.. (1991). Production and related variables in bovine leukaemia virus-infected cows. Veterinary Research Communications. 15(6). 463–474. 26 indexed citations
11.
Laing, Elizabeth J., et al.. (1989). Half-Body Radiotherapy in the Treatment of Canine Lymphoma. Journal of Veterinary Internal Medicine. 3(2). 102–108. 35 indexed citations
12.
Laing, Elizabeth J., et al.. (1989). Half-Body Radiotherapy. Journal of Veterinary Internal Medicine. 3(2). 96–101. 16 indexed citations
13.
Withrow, Stephen J., et al.. (1987). Chemotherapy of canine lymphoma with histopathological correlation: doxorubicin alone compared to COP as first treatment regimen. Journal of the American Animal Hospital Association. 73 indexed citations
14.
Chu, I., et al.. (1987). Pentachlorotoluene and pentabromotoluene: Results of a subacute and a subchronic toxicity study in the rat. Journal of Environmental Science and Health Part B. 22(3). 303–317. 3 indexed citations
15.
Heeney, Jonathan L. & V. E. Valli. (1985). Bovine ocular squamous cell carcinoma: an epidemiological perspective.. PubMed Central. 49(1). 197–205. 33 indexed citations
16.
Norris, Alan, George Harauz, Güneş N. Ege, et al.. (1982). Lymphoscintigraphy in canine mammary neoplasia. American Journal of Veterinary Research. 43(2). 195–198. 13 indexed citations
17.
Chu, I., et al.. (1981). Sub-acute and sub-chronic toxicity ofmono-2-ethylhexyl phthalate in the rat. Archives of Environmental Contamination and Toxicology. 10(3). 271–280. 6 indexed citations
18.
Chu, I., D. C. Villeneuve, V. E. Valli, V. E. Secours, & G.C. Becking. (1981). Chronic toxicity of photomirex in the rat. Toxicology and Applied Pharmacology. 59(2). 268–278. 7 indexed citations
19.
Jacobs, R. M., V. E. Valli, & B.N. Wilkie. (1980). Inhibition of Lymphocyte Blastogenesis by Sera from Cows with Lymphoma. American Journal of Veterinary Research. 41(3). 372–376. 17 indexed citations
20.
Valli, V. E. & Hollis N. Erb. (1977). Idiopathic immune hemolytic anemia with deficient remodelling of medullary bone in a Holstein calf.. Munich Personal RePEc Archive (Ludwig Maximilian University of Munich). 18(8). 222–7. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026